Skip to main content
Top

Clinical and Translational Oncology

Issue 7/2011

Content (12 Articles)

Editorial

Treatment of cervical cancer: the importance of a multidisciplinary team approach

J. Alejandro Pérez Fidalgo, Ana Hernández Machancoses, Víctor Martín González, Andrés Cervantes

Educational Series / Blue Series

Update on the diagnosis of cancer of unknown primary (CUP) origin

Aurelio Ariza, Carmen Balañá, Ángel Concha, Ricardo Hitt, Blanca Homet, Alfredo Matilla, Emilio Alba

Educational Series / Green Series

Between Scylla and Charibdis: eIF2α kinases as targets for cancer chemotherapy

Marta Moreno-Torres, José R. Murguía

Educational Series / Red Series

Overview of preoperative radiochemotherapy in breast cancer: past or future?

Céline Bourgier, Felipe A. Calvo, Hugo Marsiglia, Miguel Martín

Educational Series / Yellow Series

Is trastuzumab-induced cardiotoxicity involved in onco-cardiology outcome?

Teresa Alonso Gordoa, José Ángel García-Sáenz, Juan Francisco Rodríguez Moreno, Francisco José Hernández Pérez, Eduardo Díaz-Rubio

Special Article

Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel

Dolores Isla, Nuria González-Rojas, Diana Nieves, Max Brosa, Henrik W. Finnern

Research Articles

Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy

José Luis López Guerra, Antonio José Lozano, Joan Pera, Cristina Gutiérrez, María Cambray, Ferran Ferrer, Ferran Guedea

Research Articles

Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer

Manuel E. González, Osvaldo H. Giannini, Pablo González, Barbara Saldaña

Research Articles

Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials

Jordi Ginés, Eliazar Sabater, Clara Martorell, María Grau, Marta Monroy, Miguel A. Casado

Research Articles

Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer

Viren Asher, Joanne Lee, Anni Innamaa, Anish Bali

Research Articles

Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy

Ana Reig, Ismael Membrive, Palmira Foro, Xavier Sanz, Núria Rodríguez, Joan Lozano, Martí Lacruz, Jaume Quera, Enric Fernández-Velilla, Manuel Algara

Research Articles

Maltose-binding protein isolated from Escherichia coli induces Toll-like receptor 2-mediated viability in U937 cells

Zhao Xiaoxia, Ni Weihua, Zhang Qingyong, Wang Fengli, Li Yingying, Sun Xiaxia, Liu Zhonghui, Tai Guixiang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine